Dr. Dailey-Sterling studies unstable angina, a condition characterized by sudden chest pain due to reduced blood flow in the heart. His research investigates how different treatments can better manage this condition, particularly through the use of newer medications that target blood components responsible for clotting. By examining various drug options, he seeks to find more effective ways to keep arteries open and improve overall heart health for patients suffering from unstable angina.
Key findings
Newer drug options, including direct thrombin inhibitors, have been found to be more effective than traditional treatments in managing unstable angina.
Glycoprotein IIb/IIIa antagonists significantly help in preventing blood clots, which can alleviate symptoms of unstable angina.
Research indicates that targeted treatments can reduce the risk of complications and improve the quality of life for patients with unstable angina.
Frequently asked questions
Does Dr. Dailey-Sterling study unstable angina?
Yes, Dr. Dailey-Sterling specializes in researching treatments for unstable angina.
What treatments has Dr. Dailey-Sterling researched?
He has researched new drug options like direct thrombin inhibitors and glycoprotein IIb/IIIa antagonists to improve management of unstable angina.
Is Dr. Dailey-Sterling's work relevant to heart patients?
Yes, his work focuses directly on improving outcomes for patients experiencing unstable angina.
Publications in plain English
Wall passivation for unstable angina.
1996
Seminars in interventional cardiology : SIIC
Lettino M, Dailey-Sterling F, Badimon L, Chesebro JH, Badimon JJ
Plain English This study looked at how certain treatments can help manage unstable angina, a condition caused by the blockage of blood flow in the heart due to abnormal plaque in the arteries. Researchers found that newer drug options may be more effective than existing treatments in preventing blood clots. Specifically, using drugs that target platelets, like direct thrombin inhibitors and glycoprotein IIb/IIIa antagonists, could help keep arteries open and improve heart health.
Who this helps: This helps patients with unstable angina.